SCHEMBL3885088

SCHEMBL3885088

NC(=O)c1cccc2s[nH]c(=O)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ DDAH1 O94760 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ CACNA1B Q00975 1/20 0.43
▸ APBA1 Q02410 1/20 0.43
▸ PARP1 P09874 13/20 0.40
▸ PARP2 Q9UGN5 5/20 0.40
▸ GLA P06280 1/20 0.40
▸ AURKA O14965 2/20 0.38
▸ KEAP1 Q14145 1/20 0.38
▸ NFE2L2 Q16236 1/20 0.38
▸ PDPK1 O15530 1/20 0.38
▸ HPGD P15428 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ PLK4 O00444 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17272799 0.79 KDM4E (0.45) ALDH1A1KDM4EMAPTDDAH1LMNA
SCHEMBL8596062 0.74 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTDDAH1LMNA
SCHEMBL11499817 0.71 KDM4E (0.39) ALDH1A1KDM4EMAPTDDAH1LMNA
SCHEMBL2970289 0.71 MAPT (0.48) ALDH1A1KDM4EMAPTDDAH1LMNA
SCHEMBL725796 0.71 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTDDAH1LMNA
SCHEMBL3290161 0.68 ALOX5 (0.51) ALDH1A1KDM4EMAPTPARP1PARP2
SCHEMBL30418394 0.68 ALOX5 (0.51) ALDH1A1KDM4EMAPTPARP1PARP2
SCHEMBL3257120 0.67 MAOA (0.49) ALDH1A1KDM4EMAPTLMNAGLA
SCHEMBL7115218 0.67 LIMK1 (0.50) ALDH1A1KDM4EMAPTGLAHPGD
SCHEMBL157601 0.66 KDM4E (0.55) ALDH1A1KDM4EMAPTPARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595403-B2 Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors ELI LILLY AND COMPANY (US) 2009-09-29 — — US disclosed
US-20060276522-A1 Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors ELI LILLY AND COMPANY (US) 2006-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276522-A1 Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors LIPG, PNLIP, LIPC ALDH1A1 464/4885KDM4E 3575/4885MAPT 4397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback